Insider · CIK 0001624401
Steven Simonson
Files at WINT (WINDTREE THERAPEUTICS INC /DE/). First filing -, latest -.
In brief
Steven Simonson files SEC Form 4 as officer at WINT (WINDTREE THERAPEUTICS INC /DE/). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Steven Simonson has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 22, 2024 | WINT WINDTREE THERAPEUTICS INC /DE/ | AGrant or award Series C Preferred Stockderivative | +13 | - | - | 13 | Jul 24, 2024 |
| Jul 22, 2024 | WINT WINDTREE THERAPEUTICS INC /DE/ | AGrant or award Warrants (Right to Buy)derivative | +2,674 | - | - | 2,674 | Jul 24, 2024 |
| Feb 28, 2023 | WINT WINDTREE THERAPEUTICS INC /DE/ | FTax withholding Common Stock | -100 | $0.00 | $0 | 1,573 | Mar 2, 2023 |
Questions about Steven Simonson
Answered from the filings on this page, as of the latest one.
Is Steven Simonson buying or selling?
Steven Simonson has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Steven Simonson's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Steven Simonson has 0.
Where does Steven Simonson file Form 4?
Steven Simonson has filed Form 4 at WINT (WINDTREE THERAPEUTICS INC /DE/) as SVP, Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.